BlackRock Group’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $181K | Hold |
7,615
| – | – | ﹤0.01% | 2676 |
|
|
2016
Q3 | $279K | Hold |
7,615
| – | – | ﹤0.01% | 2497 |
|
|
2016
Q2 | $170K | Hold |
7,615
| – | – | ﹤0.01% | 2624 |
|
|
2016
Q1 | $158K | Hold |
7,615
| – | – | ﹤0.01% | 2623 |
|
|
2015
Q4 | $231K | Buy |
7,615
+408
| +6% | +$12.4K | ﹤0.01% | 2470 |
|
|
2015
Q3 | $178K | Hold |
7,207
| – | – | ﹤0.01% | 2549 |
|
|
2015
Q2 | $231K | Buy |
7,207
+4,298
| +148% | +$138K | ﹤0.01% | 2524 |
|
|
2015
Q1 | $104K | Sell |
2,909
-19,883
| -87% | -$711K | ﹤0.01% | 2637 |
|
|
2014
Q4 | $517K | Sell |
22,792
-37,033
| -62% | -$840K | ﹤0.01% | 2211 |
|
|
2014
Q3 | $1.16M | Buy |
59,825
+2,196
| +4% | +$42.6K | ﹤0.01% | 1677 |
|
|
2014
Q2 | $2.09M | Buy |
57,629
+41,151
| +250% | +$1.49M | ﹤0.01% | 1422 |
|
|
2014
Q1 | $639K | Sell |
16,478
-137
| -0.8% | -$5.31K | ﹤0.01% | 2134 |
|
|
2013
Q4 | $474K | Hold |
16,615
| – | – | ﹤0.01% | 2221 |
|
|
2013
Q3 | $595K | Buy |
16,615
+2,567
| +18% | +$91.9K | ﹤0.01% | 2141 |
|
|
2013
Q2 | $470K | Buy |
+14,048
| New | +$470K | ﹤0.01% | 2054 |
|